Instil Bio, Inc.

NASDAQ:TIL

58.75 (USD) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

20232022202120202019
Operating Activities:
Net Income -156.087-223.177-156.794-37.738-6.522
Depreciation & Amortization 4.7565.9872.7520.2560.02
Deferred Income Tax 1.12900.71-0.6430
Stock Based Compensation 18.16630.44126.1971.7060.293
Change In Working Capital -9.016-9.5664.3611.4750.366
Accounts Receivables 00000
Inventory 00000
Accounts Payables -1.129-1.8063.862-1.0540.309
Other Working Capital -7.887-7.760.4992.5290.057
Other Non Cash Items 59.02316.1510.6365.3280.55
Operating Cash Flow -82.029-180.164-122.138-29.616-5.293
Investing Activities:
Investments In Property Plant And Equipment -20.663-84.589-57.831-50.816-0.76
Acquisitions Net 01.1740-0.3060
Purchases Of Investments -301.466-666.22-1,107.56500
Sales Maturities Of Investments 361.7865.3569100
Other Investing Activites 1.557-1.17400-0.55
Investing Cash Flow 41.128114.541-474.396-51.122-0.76
Financing Activities:
Debt Repayment -8.082-70.338000
Common Stock Issued 01.548393.233312.98314.948
Common Stock Repurchased 00000
Dividends Paid 00000
Other Financing Activities 8.082140.676-0.0690.0650
Financing Cash Flow 8.08271.886393.164313.04814.948
Other Information:
Effect Of Forex Changes On Cash -0.201-0.637-0.3040.5590
Net Change In Cash -33.025.626-203.674232.8698.895
Cash At End Of Period 10.69643.71638.09241.7648.895